{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:05:36Z","timestamp":1788858336526,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70113814"],"award-info":[{"award-number":["70113814"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Prostate cancer (PCa) is a public health problem mostly reported in developed countries. The androgen receptor (AR) regulates the development and physiological function of normal prostate as well as the proliferation of cancerous prostate tissue. Treatment with supraphysiological androgen levels (SAL) is used in bipolar androgen therapy and inhibits PCa growth, suggesting SAL induces a tumor suppressive program. It was shown that SAL induces cellular senescence, in PCa cell lines, human tumor samples and in xenografted mouse tumor model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Transcriptome and ChIP-seq analysis, PCa spheroids, knockdown (KD), co-immunoprecipitation, qRT-PCR, immune detection, in situ histochemistry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here we show that LYL1 is upregulated by the clock gene BHLHE40 in both C4-2 and LNCaP cells and mediates SAL-induced cellular senescence. LYL1 is a transcriptional co-factor with oncogenic activity in leukemia. However, analysis of a large cohort of PCa patients shows that LYL1 expression is reduced during PCa development and reduced expression is significantly associated with reduced overall survival. SAL induces the expression of LYL1 through upregulation of BHLHE40. On the other hand, the KD of <jats:italic>LYL1<\/jats:italic> enhances BHLHE40 expression via a negative feedback loop including p27kip1. Regulatory feedback loops were identified by rescue experiments. Functional analysis revealed that KD of <jats:italic>BHLHE40<\/jats:italic> reduces whereas <jats:italic>LYL1<\/jats:italic> KD enhances p27kip1 levels. The KD of p27kip1 suggests that this cell cycle inhibitor is a mediator of cellular senescence by the BHLHE40 - LYL1 regulatory loop. Interestingly, ChIP-seq data revealed recruitment of both AR and BHLHE40 to the LYL1 gene indicating that LYL1 is a novel direct target of both factors. Furthermore, RNA-seq data from C4-2 cells suggests that LYL1 and BHLHE40 encompass a large overlap of genes by SAL suggesting a co-regulatory activity controlled by androgens. In line with this, co-immunoprecipitation suggests LYL1 is in a complex with BHLHE40 and the AR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Three novel feed-back loops and a novel AR- BHLHE40 \/ LYL1 -p27kip1 axis has been identified mediating cellular senescence in PCa cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12964-024-01970-7","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T07:42:07Z","timestamp":1733989327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence"],"prefix":"10.1186","volume":"22","author":[{"given":"Mehdi","family":"Heidari Horestani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria","family":"Baniahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"1","key":"1970_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"34","key":"1970_CR2","doi-asserted-by":"publisher","first-page":"12182","DOI":"10.1073\/pnas.0804700105","volume":"105","author":"Y Niu","year":"2008","unstructured":"Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, et al. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci. 2008;105(34):12182\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"1970_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-022-00941-0","volume":"12","author":"J Kallenbach","year":"2022","unstructured":"Kallenbach J, Atri Roozbahani G, Heidari Horestani M, Baniahmad A. Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer. Cell Bioscience. 2022;12(1):1\u201317.","journal-title":"Cell Bioscience"},{"issue":"5","key":"1970_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.juro.2018.04.083","volume":"200","author":"ED Crawford","year":"2018","unstructured":"Crawford ED, Schellhammer PF, McLeod DG, Moul JW, Higano CS, Shore N, et al. Androgen receptor targeted treatments of prostate cancer: 35 years of progress with antiandrogens. J Urol. 2018;200(5):956\u201366.","journal-title":"J Urol"},{"key":"1970_CR5","doi-asserted-by":"crossref","unstructured":"Feng Q, He B. Androgen receptor signaling in the development of castration-resistant prostate cancer. Front Oncol. 2019:858.","DOI":"10.3389\/fonc.2019.00858"},{"issue":"1","key":"1970_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-13-214","volume":"13","author":"J Roediger","year":"2014","unstructured":"Roediger J, Hessenkemper W, Bartsch S, Manvelyan M, Huettner SS, Liehr T, et al. Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the src-akt pathway. Mol Cancer. 2014;13(1):1\u201315.","journal-title":"Mol Cancer"},{"key":"1970_CR7","doi-asserted-by":"crossref","unstructured":"Isaacs JT, Brennen WN, Denmeade SR. Serial bipolar androgen therapy (sBAT) using cyclic supraphysiologic testosterone (STP) to treat metastatic castration-resistant prostate cancer (mCRPC). Annals Translational Med. 2019;7(Suppl 8).","DOI":"10.21037\/atm.2019.10.32"},{"issue":"12","key":"1970_CR8","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1200\/JCO.20.02759","volume":"39","author":"SR Denmeade","year":"2021","unstructured":"Denmeade SR, Wang H, Agarwal N, Smith DC, Schweizer MT, Stein MN, et al. TRANSFORMER: a randomized phase II study comparing bipolar androgen therapy versus enzalutamide in asymptomatic men with castration-resistant metastatic prostate cancer. J Clin Oncol. 2021;39(12):1371.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1970_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.eururo.2020.06.042","volume":"79","author":"MC Markowski","year":"2021","unstructured":"Markowski MC, Wang H, Sullivan R, Rifkind I, Sinibaldi V, Schweizer MT, et al. A multicohort open-label phase II trial of bipolar androgen therapy in men with metastatic castration-resistant prostate cancer (RESTORE): a comparison of post-abiraterone versus post-enzalutamide cohorts. Eur Urol. 2021;79(5):692\u20139.","journal-title":"Eur Urol"},{"issue":"8","key":"1970_CR10","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/ijc.31818","volume":"144","author":"G Lakshmana","year":"2019","unstructured":"Lakshmana G, Baniahmad A. Interference with the androgen receptor protein stability in therapy-resistant prostate cancer. Int J Cancer. 2019;144(8):1775\u20139.","journal-title":"Int J Cancer"},{"issue":"23","key":"1970_CR11","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1038\/s41388-022-02333-7","volume":"41","author":"M Ehsani","year":"2022","unstructured":"Ehsani M, Bartsch S, Rasa SMM, Dittmann J, Pungsrinont T, Neubert L, et al. The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2. Oncogene. 2022;41(23):3263\u201377.","journal-title":"Oncogene"},{"issue":"1","key":"1970_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-020-00422-2","volume":"10","author":"T Pungsrinont","year":"2020","unstructured":"Pungsrinont T, Sutter MF, Ertingshausen MC, Lakshmana G, Kokal M, Khan AS, et al. Senolytic compounds control a distinct fate of androgen receptor agonist-and antagonist-induced cellular senescent LNCaP prostate cancer cells. Cell Bioscience. 2020;10(1):1\u201313.","journal-title":"Cell Bioscience"},{"issue":"4","key":"1970_CR13","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.celrep.2016.09.064","volume":"17","author":"S Gao","year":"2016","unstructured":"Gao S, Gao Y, He HH, Han D, Han W, Avery A, et al. Androgen receptor tumor suppressor function is mediated by recruitment of retinoblastoma protein. Cell Rep. 2016;17(4):966\u201376.","journal-title":"Cell Rep"},{"issue":"19","key":"1970_CR14","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1016\/j.bmc.2010.08.029","volume":"18","author":"MA Fousteris","year":"2010","unstructured":"Fousteris MA, Schubert U, Roell D, Roediger J, Bailis N, Nikolaropoulos SS, et al. 20-Aminosteroids as a novel class of selective and complete androgen receptor antagonists and inhibitors of prostate cancer cell growth. Bioorg Med Chem. 2010;18(19):6960\u20139.","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"1970_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41388-021-02060-5","volume":"41","author":"K Mirzakhani","year":"2022","unstructured":"Mirzakhani K, Kallenbach J, Rasa SMM, Ribaudo F, Ungelenk M, Ehsani M, et al. The androgen receptor\u2014lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells. Oncogene. 2022;41(7):943\u201359.","journal-title":"Oncogene"},{"issue":"10","key":"1970_CR16","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1172\/JCI127613","volume":"129","author":"P Chatterjee","year":"2019","unstructured":"Chatterjee P, Schweizer MT, Lucas JM, Coleman I, Nyquist MD, Frank SB, et al. Supraphysiological androgens suppress prostate cancer growth through androgen receptor\u2013mediated DNA damage. J Clin Investig. 2019;129(10):4245\u201360.","journal-title":"J Clin Investig"},{"issue":"1","key":"1970_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5483\/BMBRep.2019.52.1.294","volume":"52","author":"S Lee","year":"2019","unstructured":"Lee S, Lee J-S. Cellular senescence: a promising strategy for cancer therapy. BMB Rep. 2019;52(1):35.","journal-title":"BMB Rep"},{"issue":"2","key":"1970_CR18","doi-asserted-by":"publisher","first-page":"a026112","DOI":"10.1101\/cshperspect.a026112","volume":"7","author":"CA Tonnessen-Murray","year":"2017","unstructured":"Tonnessen-Murray CA, Lozano G, Jackson JG. The regulation of cellular functions by the p53 protein: cellular senescence. Cold Spring Harbor Perspect Med. 2017;7(2):a026112.","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"16","key":"1970_CR19","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.3390\/cancers13164025","volume":"13","author":"S Bartsch","year":"2021","unstructured":"Bartsch S, Mirzakhani K, Neubert L, Stenzel A, Ehsani M, Esmaeili M, et al. Antithetic hTERT regulation by androgens in prostate cancer cells: hTERT inhibition is mediated by the ING1 and ING2 tumor suppressors. Cancers. 2021;13(16):4025.","journal-title":"Cancers"},{"issue":"1","key":"1970_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-024-03097-6","volume":"43","author":"M Heidari Horestani","year":"2024","unstructured":"Heidari Horestani M, Atri Roozbahani G, Baniahmad A. The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer. J Experimental Clin Cancer Res. 2024;43(1):1\u201319.","journal-title":"J Experimental Clin Cancer Res"},{"key":"1970_CR21","doi-asserted-by":"crossref","unstructured":"Miyamoto A, Cui X, Naumovski L, Cleary ML. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells. Molecular and cellular biology. 1996;16(5):2394\u2013401.","DOI":"10.1128\/MCB.16.5.2394"},{"issue":"48","key":"1970_CR22","doi-asserted-by":"publisher","first-page":"6937","DOI":"10.1038\/sj.onc.1210494","volume":"26","author":"Y Zhong","year":"2007","unstructured":"Zhong Y, Jiang L, Hiai H, Toyokuni S, Yamada Y. Overexpression of a transcription factor LYL1 induces T-and B-cell lymphoma in mice. Oncogene. 2007;26(48):6937\u201347.","journal-title":"Oncogene"},{"issue":"1","key":"1970_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13046-022-02428-9","volume":"41","author":"F Fang","year":"2022","unstructured":"Fang F, Lu J, Sang X, Tao Y-F, Wang J-W, Zhang Z-M, et al. Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia. J Experimental Clin Cancer Res. 2022;41(1):225.","journal-title":"J Experimental Clin Cancer Res"},{"key":"1970_CR24","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00109-016-1440-1","volume":"94","author":"M Esmaeili","year":"2016","unstructured":"Esmaeili M, Pungsrinont T, Schaefer A, Baniahmad A. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling. J Mol Med. 2016;94:1167\u201379.","journal-title":"J Mol Med"},{"issue":"3\u20134","key":"1970_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12672-020-00391-5","volume":"11","author":"S Gupta","year":"2020","unstructured":"Gupta S, Pungsrinont T, \u017denata O, Neubert L, Vrzal R, Baniahmad A. Interleukin-23 represses the level of cell Senescence Induced by the androgen receptor antagonists Enzalutamide and Darolutamide in Castration-resistant prostate Cancer cells. Horm Cancer. 2020;11(3\u20134):182\u201390.","journal-title":"Horm Cancer"},{"issue":"3","key":"1970_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/jmcb\/mjw007","volume":"8","author":"M Esmaeili","year":"2016","unstructured":"Esmaeili M, Jennek S, Ludwig S, Klitzsch A, Kraft F, Melle C, et al. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells. J Mol Cell Biol. 2016;8(3):207\u201320.","journal-title":"J Mol Cell Biol"},{"issue":"20","key":"1970_CR27","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1101\/gad.267278.115","volume":"29","author":"M Chen","year":"2015","unstructured":"Chen M, Zhu N, Liu X, Laurent B, Tang Z, Eng R, et al. JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors. Genes Dev. 2015;29(20):2123\u201339.","journal-title":"Genes Dev"},{"issue":"17","key":"1970_CR28","doi-asserted-by":"publisher","first-page":"9606","DOI":"10.1093\/nar\/gkaa705","volume":"48","author":"G Hu","year":"2020","unstructured":"Hu G, Dong X, Gong S, Song Y, Hutchins AP, Yao H. Systematic screening of CTCF binding partners identifies that BHLHE40 regulates CTCF genome-wide distribution and long-range chromatin interactions. Nucleic Acids Res. 2020;48(17):9606\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1970_CR29","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ymthe.2022.01.039","volume":"30","author":"W Han","year":"2022","unstructured":"Han W, Liu M, Han D, Toure AA, Li M, Besschetnova A, et al. Exploiting the tumor-suppressive activity of the androgen receptor by CDK4\/6 inhibition in castration-resistant prostate cancer. Mol Ther. 2022;30(4):1628\u201344.","journal-title":"Mol Ther"},{"issue":"42","key":"1970_CR30","doi-asserted-by":"publisher","first-page":"e2213718119","DOI":"10.1073\/pnas.2213718119","volume":"119","author":"Q Chen","year":"2022","unstructured":"Chen Q, Cevher MA, Jiang Q, Wang S, Sun X, Roeder RG, et al. LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t (8; 21) AML. Proc Natl Acad Sci. 2022;119(42):e2213718119.","journal-title":"Proc Natl Acad Sci"},{"issue":"20","key":"1970_CR31","doi-asserted-by":"publisher","first-page":"32990","DOI":"10.18632\/oncotarget.16518","volume":"8","author":"AS Nikitina","year":"2017","unstructured":"Nikitina AS, Sharova EI, Danilenko SA, Butusova TB, Vasiliev AO, Govorov AV, et al. Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients. Oncotarget. 2017;8(20):32990.","journal-title":"Oncotarget"},{"key":"1970_CR32","doi-asserted-by":"crossref","unstructured":"Luo G, Li G, Wan Z, Zhang Y, Liu D, Guo Y. circITGA7 Acts as a miR-370-3p sponge to suppress the proliferation of prostate cancer. Journal of Oncology. 2021;2021:32990\u20133001.","DOI":"10.1155\/2021\/8060389"},{"issue":"1","key":"1970_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1158\/1055-9965.EPI-17-0461","volume":"27","author":"J Brouwer-Visser","year":"2018","unstructured":"Brouwer-Visser J, Cheng W-Y, Bauer-Mehren A, Maisel D, Lechner K, Andersson E, et al. Regulatory T-cell genes drive altered immune microenvironment in adult solid cancers and allow for immune contextual patient subtyping. Cancer Epidemiol Biomarkers Prev. 2018;27(1):103\u201312.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"1970_CR34","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/1878-0261.12693","volume":"14","author":"SJ Baumgart","year":"2020","unstructured":"Baumgart SJ, Nevedomskaya E, Lesche R, Newman R, Mumberg D, Haendler B. Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation. Mol Oncol. 2020;14(9):2022\u201339.","journal-title":"Mol Oncol"},{"key":"1970_CR35","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3389\/fgene.2019.00858","volume":"10","author":"E Ulgen","year":"2019","unstructured":"Ulgen E, Ozisik O, Sezerman OU. pathfindR: an R package for comprehensive identification of enriched pathways in omics data through active subnetworks. Front Genet. 2019;10:858.","journal-title":"Front Genet"},{"key":"1970_CR36","doi-asserted-by":"crossref","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov. 2021;2(3).","DOI":"10.1016\/j.xinn.2021.100141"},{"issue":"5","key":"1970_CR37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"4","key":"1970_CR38","first-page":"1","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(4):1\u20137.","journal-title":"BMC Syst Biol"},{"issue":"11","key":"1970_CR39","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"key":"1970_CR40","doi-asserted-by":"crossref","unstructured":"Damian Szklarczyk AF, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Lars J, Jensen. Christian von Mering. STRING v10: protein-protein interaction networks, integrated over the tree of life 2015.\u00a0https:\/\/www.string.embl.de\/. Cited 2015 Jan, 2015.","DOI":"10.1093\/nar\/gku1003"},{"issue":"1","key":"1970_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24\u20136.","journal-title":"Nat Biotechnol"},{"issue":"W1","key":"1970_CR42","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"1970_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1\u201321.","journal-title":"Genome Biol"},{"key":"1970_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-35","volume":"12","author":"H Chen","year":"2011","unstructured":"Chen H, Boutros PC. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics. 2011;12:1\u20137.","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"1970_CR45","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.4161\/cc.29147","volume":"13","author":"JM Flores","year":"2014","unstructured":"Flores JM, Mart\u00edn-Caballero J, Garc\u00eda-Fern\u00e1ndez RA. p21 and p27 a shared senescence history. Cell Cycle. 2014;13(11):1655\u20136.","journal-title":"Cell Cycle"},{"issue":"2","key":"1970_CR46","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0002-9440(10)65277-7","volume":"154","author":"RV Lloyd","year":"1999","unstructured":"Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999;154(2):313\u201323.","journal-title":"Am J Pathol"},{"issue":"6","key":"1970_CR47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.exphem.2011.02.014","volume":"39","author":"C Capron","year":"2011","unstructured":"Capron C, Lacout C, L\u00e9cluse Y, Wagner-Ballon O, Kaushik A-L, Cramer-Bord\u00e9 E, et al. LYL-1 deficiency induces a stress erythropoiesis. Exp Hematol. 2011;39(6):629\u201342.","journal-title":"Exp Hematol"},{"issue":"5","key":"1970_CR48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41585-022-00686-y","volume":"20","author":"R Kumar","year":"2023","unstructured":"Kumar R, Sena LA, Denmeade SR, Kachhap S. The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications. Nat Reviews Urol. 2023;20(5):265\u201378.","journal-title":"Nat Reviews Urol"},{"key":"1970_CR49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fendo.2017.00311","volume":"8","author":"P-D Denechaud","year":"2017","unstructured":"Denechaud P-D, Fajas L, Giralt A. E2F1, a novel regulator of metabolism. Front Endocrinol. 2017;8:311.","journal-title":"Front Endocrinol"},{"issue":"1","key":"1970_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4473-8","volume":"18","author":"E Mosaad","year":"2018","unstructured":"Mosaad E, Chambers K, Futrega K, Clements J, Doran MR. Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures. BMC Cancer. 2018;18(1):1\u201311.","journal-title":"BMC Cancer"},{"issue":"2","key":"1970_CR51","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu J, Lamouille S, Derynck R. TGF-\u03b2-induced epithelial to mesenchymal transition. Cell Res. 2009;19(2):156\u201372.","journal-title":"Cell Res"},{"issue":"11","key":"1970_CR52","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/ijms20112767","volume":"20","author":"Y Hao","year":"2019","unstructured":"Hao Y, Baker D, Ten Dijke P. TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019;20(11):2767.","journal-title":"Int J Mol Sci"},{"key":"1970_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11010-016-2794-y","volume":"421","author":"J Colditz","year":"2016","unstructured":"Colditz J, Rupf B, Maiwald C, Baniahmad A. Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells. Mol Cell Biochem. 2016;421:139\u201347.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"1970_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/aps.2014.18","volume":"36","author":"M Tan","year":"2015","unstructured":"Tan M, Li J, Xu HE, Melcher K, Yong E-l. Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin. 2015;36(1):3\u201323.","journal-title":"Acta Pharmacol Sin"},{"key":"1970_CR55","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3389\/fonc.2019.00858","volume":"9","author":"Q Feng","year":"2019","unstructured":"Feng Q, He B. Androgen receptor signaling in the development of castration-resistant prostate cancer. Front Oncol. 2019;9:858.","journal-title":"Front Oncol"},{"issue":"1","key":"1970_CR56","doi-asserted-by":"publisher","first-page":"16400","DOI":"10.1038\/s41598-023-43577-x","volume":"13","author":"W Qi","year":"2023","unstructured":"Qi W, Liu Q, Fu W, Shi J, Shi M, Duan S, et al. BHLHE40, a potential immune therapy target, regulated by FGD5-AS1\/miR-15a-5p in pancreatic cancer. Sci Rep. 2023;13(1):16400.","journal-title":"Sci Rep"},{"issue":"4","key":"1970_CR57","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.onc.1202374","volume":"18","author":"R Ferrier","year":"1999","unstructured":"Ferrier R, Nougarede R, Doucet S, Kahn-Perles B, Imbert J, Mathieu-Mahul D. Physical interaction of the bHLH LYL1 protein and NF-\u03baB1 p105. Oncogene. 1999;18(4):995\u20131005.","journal-title":"Oncogene"},{"issue":"12","key":"1970_CR58","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1182\/blood-2005-08-3145","volume":"107","author":"C Capron","year":"2006","unstructured":"Capron C, L\u00e9cluse Y, Kaushik AL, Foudi A, Lacout C, Sekkai D, et al. The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation. Blood. 2006;107(12):4678\u201386.","journal-title":"Blood"},{"issue":"1","key":"1970_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0092-8674(89)90404-2","volume":"58","author":"JD Mellentin","year":"1989","unstructured":"Mellentin JD, Smith SD, Cleary ML. lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell. 1989;58(1):77\u201383.","journal-title":"Cell"},{"issue":"5","key":"1970_CR60","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3892\/ol.2013.1563","volume":"6","author":"H Sirma","year":"2013","unstructured":"Sirma H, Broemel M, Stumm L, Tsourlakis T, Steurer S, Tennstedt P, et al. Loss of CDKN1B\/p27Kip1 expression is associated with ERG fusion\u2013negative prostate cancer, but is unrelated to patient prognosis. Oncol Lett. 2013;6(5):1245\u201352.","journal-title":"Oncol Lett"},{"issue":"9","key":"1970_CR61","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1002\/cam4.1720","volume":"7","author":"W Zhou","year":"2018","unstructured":"Zhou W, Wang J, Qi Q, Feng Z, Huang B, Chen A, et al. Matrine induces senescence of human glioblastoma cells through suppression of the IGF1\/PI3K\/AKT\/p27 signaling pathway. Cancer Med. 2018;7(9):4729\u201343.","journal-title":"Cancer Med"},{"issue":"12","key":"1970_CR62","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1080\/15548627.2020.1831217","volume":"16","author":"A Nowosad","year":"2020","unstructured":"Nowosad A, Besson A. CDKN1B\/p27 regulates autophagy via the control of Ragulator and MTOR activity in amino acid-deprived cells. Autophagy. 2020;16(12):2297\u20138.","journal-title":"Autophagy"},{"key":"1970_CR63","doi-asserted-by":"publisher","first-page":"916682","DOI":"10.3389\/fonc.2022.916682","volume":"12","author":"A Schirripa","year":"2022","unstructured":"Schirripa A, Sexl V, Kollmann K. Cyclin-dependent kinase inhibitors in malignant hematopoiesis. Front Oncol. 2022;12:916682.","journal-title":"Front Oncol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01970-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01970-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01970-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T09:03:19Z","timestamp":1733994199000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01970-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01970-7","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"590"}}